Healthcare News - An Overview
FTC sues major pharmacy benefit administrators above insulin charges The agency introduced action towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list cost of lifestyle-saving insulin medicine.This approach aligns with Those people attempts, the ONC